Navigation Links
Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines
Date:4/30/2008

ity genetic variation and mutation analysis. Their offerings include systems, products, discovery and laboratory testing services to the academic and medical research, clinical laboratory and pharmaceutical markets in the fields of Pharmacogenomics and personalized medicine. Specific offerings include WAVE(R) DHPLC Systems, related consumables and assay kits, Cytogenetics automated systems, and Transgenomic Pharmacogenomics and Reference Laboratory Services. Transgenomic Pharmacogenomics and Laboratory Services utilize their technology and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 validated diagnostic tests to meet the needs of pharmaceutical and biotech companies, research and clinical laboratories, physicians and patients. For more information about the innovative systems, products and services offered by Transgenomic, please visit: http://www.transgenomic.com.

Transgenomic Cautionary Statements

Certain statements in this press release constitute "forward-looking statements" of Transgenomic within the meaning of the Private Securities Litigation Reform Act of 1995, which involve known and unknown risks, uncertainties and other factors that may cause our actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Forward-looking statements include, but are not limited to, those with respect to management's current views and estimates of future economic circumstances, industry conditions, company performance and financial results, including the ability of the Company to grow its involvement in the diagnostic products and services markets. The known risks, uncertainties and other factors affecting these forward-looking statements are described from time to time in Transgenomic's reports to the Securities and Exchange Commission. Any change in such factors, r
'/>"/>

SOURCE Transgenomic, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
2. Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay
3. ALS Therapy Development Institute Signs Collaboration Agreement with the Allen Institute for Brain Science
4. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
5. Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing
6. QIAGEN and Center for Molecular Medicine Create Research Collaboration for Molecular Diagnostic Markers for Breast Cancer, Other Womens Health Issues
7. Celltrion and CSL Announce Collaboration to Develop and Manufacture Monoclonal Antibody
8. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
9. Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
10. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
11. Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... , May 29, 2015 LifeNet Health ... total hiring for 2015 to more than 160 people. ... increased demand for LifeNet Health,s innovative bio-implants, which are ... more patients to be served. It also is a ... industry. "The growth and success of LifeNet ...
(Date:5/29/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/ltwldz/surgicaloperating ... "Surgical/Operating Microscopes Market by Application & End User ... their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... to reach $806.6 million by 2020 from $402.2 ... from 2015 to 2020. , ,Major factors fueling ...
(Date:5/29/2015)... May 29, 2015  Haemonetics Corporation (NYSE: HAE ... Operating Officer, will present at the JMP Securities Life ... on June 23 rd , 2015 at 11:30am Eastern ... Davies, presentation live via webcast at: http://wsw.com/webcast/jmp27/hae ... HAE ) is a global healthcare company dedicated to ...
Breaking Medicine Technology:LifeNet Health to add more than 160 jobs in 2015 2Surgical/Operating Microscopes Market by Application & End User - Global Forecast to 2020 for the $806 Million Industry 2
... Dec. 13, 2010 The creators of the innovative Pill Timer, ... and a much needed medication management system to pediatric patients ... Broward General, in Fort Lauderdale, Florida. Representatives ... be onsite Wednesday, December 15, from 1-3 pm distributing the ...
... IRVINE, Calif., Dec. 13, 2010 Masimo ... that a new clinical study demonstrating the accuracy of ... presented last week at the American Association of ... in Las Vegas. The largest gathering of respiratory care ...
Cached Medicine Technology:Med Time Technology, Inc. Teams up with Give A Smile, Inc. to Provide Pill Timer™ Kits and Toys to Children and Parents at the Chris Evert Children's Hospital of Broward General 2New Clinical Study Presented at the American Association of Respiratory Care Finds Masimo Rainbow Acoustic Monitoring Accurate for Respiration Rate Assessment 2New Clinical Study Presented at the American Association of Respiratory Care Finds Masimo Rainbow Acoustic Monitoring Accurate for Respiration Rate Assessment 3New Clinical Study Presented at the American Association of Respiratory Care Finds Masimo Rainbow Acoustic Monitoring Accurate for Respiration Rate Assessment 4New Clinical Study Presented at the American Association of Respiratory Care Finds Masimo Rainbow Acoustic Monitoring Accurate for Respiration Rate Assessment 5New Clinical Study Presented at the American Association of Respiratory Care Finds Masimo Rainbow Acoustic Monitoring Accurate for Respiration Rate Assessment 6
(Date:5/29/2015)... Shaila Jiwa, a physiotherapist from Burnaby ... stated in a new announcement that patients of urinary ... commonly seen as a tabooed topic to talk about ... like Shaila Jiwa try to encourage people to come ... is a condition that can be classified under two ...
(Date:5/29/2015)... 29, 2015 The Global Allopurinol ... study on the current state of the Allopurinol ... key statistics on the state of the industry ... direction for companies and individuals interested in the ... the industry including definitions, classifications, applications and industry ...
(Date:5/29/2015)... Mirada, CA (PRWEB) May 29, 2015 ... traumatic brain injuries with the help of their licensed ... mild traumatic brain injuries can lead to an extensive ... impairments; these effects can arise at any time after ... can be caused by any bump or jolt to ...
(Date:5/29/2015)... The annual aesthetic meeting, put on by ... in Montreal from May 14-19th. This global event sets ... around the world; dedicating itself exclusively to cosmetic medicine. ... plastic surgeons to attend this year’s meeting. , Among ... Vitenas was given the honor of sitting at the presenter’s ...
(Date:5/29/2015)... Lake Orion, Clarkston, Metamora, Michigan (PRWEB) May 29, 2015 ... in the vulvar region and can cause significant physical, ... understands the major life altering disorder of Vulvodynia. The ... exclusion. At Women’s Excellence in Endometriosis, they realize that ... If a patient is experiencing any of these symptoms, ...
Breaking Medicine News(10 mins):Health News:Patients of Urinary Incontinence Should Not "Hide And Suffer," States Physiotherapist from Burnaby Physiotherapy Clinic 2Health News:Allopurinol Industry (Global, China) 2015 Research Analysis and 2020 Forecasts 2Health News:Healthpointe’s Los Angeles County Clinics Are Now Offering Treatment for Mild Traumatic Brain Injuries 2Health News:Dr. Paul Vitenas Presents at 2015 Aesthetic Meeting 2Health News:Dr. Paul Vitenas Presents at 2015 Aesthetic Meeting 3
... Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical ... ) focused on bringing the life saving ... pleased to announce that between February 15, 2009, and today, ... or 12 percent. This follows the announcement on Feb. ...
... CORPS, April 6 The United States Marine Corps ... 2009 when the city opens its doors to the ... activities throughout the Chicagoland area. "Established to recognize ... the cities from which they came, Marine Week also ...
... The nation’s most trusted distributor of plasma products, vaccines and critical-care ... well as new Fluzone® return policy. , ... (Vocus) ... vaccine distribution marketplace, FFF Enterprises, Inc., is pleased to ...
... stumbled across a cure for high blood pressure and heart disease during ... ... 2009 -- The Elmore Oil Company, a Bendigo based company who manufactures ... a double blind placebo controlled trial for their flagship product, Elmore Oil., ...
... 5 Parents can have a tremendous impact on ... learning potential. By using techniques that stimulate the brain ... enhance the child,s awareness of its environment and comprehensive ... Kang announces the launch of Spotlight Baby. Kang says, ...
... Helps Ensure Physicians Can Access Critical Patient ... From the floor of the HIMSS09 Annual ... MDRX ) today introduced Allscripts Remote(TM), a ... virtually anytime, anywhere access to and control ...
Cached Medicine News:Health News:Cord Blood Announces $1.75 Million Reduction in Long Term Debt 2Health News:Marine Corps Launches Inaugural Marine Week in Chicago, May 11-17 2Health News:Marine Corps Launches Inaugural Marine Week in Chicago, May 11-17 3Health News:FFF Named the Exclusive Distributor of Fluzone for GPOs & Announces New Fluzone Return Policy 2Health News:Arthritis Trial Leads to Potential Cure for High Blood Pressure 2Health News:Spotlight Baby Provides Parents with Educational Programs and Eco-Friendly Products to Support Babies in Reaching Their Full Developmental Potentials 2Health News:Allscripts Introduces Electronic Health Record Capability for iPhone(TM) 2Health News:Allscripts Introduces Electronic Health Record Capability for iPhone(TM) 3Health News:Allscripts Introduces Electronic Health Record Capability for iPhone(TM) 4Health News:Allscripts Introduces Electronic Health Record Capability for iPhone(TM) 5
The Oxoid Legionella Latex Test is a latex agglutination test for the identification of predominant Legionella species grown on plate media from patients with suspected Legionellosis or from environm...
... A revolutionary new agar plate for economically screening ... this biplate with the urine specimen. If the ... the chromogenic side of the biplate will 3 ... E. coli, the BluEcoli™ Urine Biplate is a ...
... The Trinity Biotech Captia™ Legionella ... (ELISA) is intended for the ... (IgG and IgM) to Legionella ... serum from patients with clinical ...
SDA is a patented isothermal amplification technology capable of generating billions of copies of target molecules from a single DNA or RNA template in just minutes....
Medicine Products: